In short
GSK plc (GSK.L) has revenue up 4.1% to GBP 32.7B and net income up 122.0% to GBP 5.7B year on year. Its net margin is 17.5% and gross margin 72.4%, and it trades at 17.6× trailing earnings. Fisclear flags 1 high-severity risk, led by: Current ratio of 0.82x — short-term liabilities exceed current assets, which could create near-term liquidity pressure. How we calculate this
Valuation
HealthcareLive · Yahoo FinancePrice
1,930p
£75.7B
8.7x
3.60%
52-Week Range
4-engine score — Quality and Peers engines require SEC EDGAR (US stocks only)
ROE 34.9% — exceptional capital return.
Operating margin 25.5% — high profitability.
FCF yield 6.3% — strong cash generation.
Based on filing period ending Dec 2025
International FisclearScore uses 4 engines (no EDGAR data). Based on Yahoo Finance & Alpha Vantage reported financials. Not financial advice.
🇬🇧 United Kingdom Macro Indicators
Full dashboard →10-Year Yield
5.24%↑
GBP/USD
1.34→
The 10-year government bond yield is 5.24%; GBP/USD is at 1.3371.
SWOT Analysis — GSK.L
Inflationary BoomStrengths
EPS (Diluted): GBP 1.39 (+123.2% YoY) — Earnings per share rose 123% — each share earned more.
Net Income: GBP 5.7B (+122.0% YoY) — Profit grew 122% — the company kept more of each dollar earned.
Operating Cash Flow: GBP 7.7B (+18.1% YoY) — Operating cash flow grew 18% — the business generated more cash from day-to-day operations.
Gross Profit: GBP 23.6B (+5.9% YoY) — Gross profit rose 6% — the spread between revenue and direct costs improved.
Weaknesses
No material weaknesses flagged.
Opportunities
Revenue: GBP 32.7B (+4.1% YoY) — Revenue grew 4% — the company sold more goods or services than the prior year.
Threats
Current ratio of 0.82x — short-term liabilities exceed current assets, which could create near-term liquidity pressure.
Total liabilities represent 74% of total assets — elevated leverage that amplifies both gains and losses.
Year-over-Year Changes
EPS (Diluted)
GBP 1.39
was GBP 0.62
Earnings per share rose 123% — each share earned more.
Net Income
GBP 5.7B
was GBP 2.6B
Profit grew 122% — the company kept more of each dollar earned.
Operating Cash Flow
GBP 7.7B
was GBP 6.6B
Operating cash flow grew 18% — the business generated more cash from day-to-day operations.
Gross Profit
GBP 23.6B
was GBP 22.3B
Gross profit rose 6% — the spread between revenue and direct costs improved.
Revenue
GBP 32.7B
was GBP 31.4B
Revenue grew 4% — the company sold more goods or services than the prior year.
Risk Flags
1 high · 1 medium · 0 low- ⚠ High
Current ratio of 0.82x — short-term liabilities exceed current assets, which could create near-term liquidity pressure.
- ◈ Medium
Total liabilities represent 74% of total assets — elevated leverage that amplifies both gains and losses.
Technical Signals
Daily closes · 1-year dataGSK plc: common questions
Is GSK plc profitable?
Yes. GSK plc made a net profit of £5.7B in its latest fiscal year (fiscal 2025), a net margin of 17.5%.
Is GSK plc's revenue growing?
Yes. Revenue grew 4.1% year on year, to GBP 32.7B.
What is GSK plc's P/E ratio?
GSK plc trades at 17.6× its trailing twelve-month earnings. In other words, the share price is about 18 times the profit per share the company earned over the past year.
Does GSK plc pay a dividend?
Yes. GSK plc's forward dividend yield is 3.60%, the expected annual dividend as a share of the current share price.
What are the main risks for GSK plc?
Fisclear's checks flag 2 medium- or high-severity risks. The most serious: Current ratio of 0.82x — short-term liabilities exceed current assets, which could create near-term liquidity pressure.
Answers are generated from the figures in this report (updated 5 Nov 2026). Information, not investment advice.
Latest News
via FinnhubFiling History — GSK.L
Get the weekly digest
5 company reports + macro context every week, free. No spam.
- Unlimited goal simulations
- 5 free company report summaries per day
- Weekly financial insights newsletter
External Links
Research GSK plc
Data sourced from London Stock Exchange (LSE), FRED (Federal Reserve), OECD, BIS, and Yahoo Finance. For informational purposes only. Not financial advice.